deltatrials
Completed PHASE1 NCT00214851

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria

Sponsor: Atlantic Provinces Dermatology Association

Interventions Kineret (anakinra)
Updated 6 times since 2017 Last updated: Nov 4, 2022 Started: Sep 30, 2005 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This PHASE1 trial investigates Familial Cold Urticaria and is currently completed. Atlantic Provinces Dermatology Association leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Dec 2022 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Atlantic Provinces Dermatology Association
  • Nova Scotia Health Authority
Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations